£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

The 2023-2028 Outlook for Schizophrenia Treatments in the United States

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 29 days · 29 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 July 2026 02 August 2026 09 August 2026 16 August 2026 23 August 2026
View at Amazon ↗

Price data last checked 62 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 29 days • 1 price levels

Days at Price
29 days 0 7 15 22 29 £520 Days at Price

Price Analysis

Most common price: £520 (29 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 29 days

Description

This study covers the latent demand outlook for schizophrenia treatments across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state and of the United States as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and city, latent demand estimates are created for schizophrenia treatments. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of schizophrenia treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AbbVie, Alkermes, Allergan, Astellas Pharma, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Gedeon Richter, Johnson & Johnson, Merz Pharma., Novartis, Otsuka Holdings Company, Pfizer, PsychoGenics, Inc., Sumitomo Dainippon Pharma Company, and Vanda Pharmaceuticals. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Schizophrenia Drugs in the United States
99% match

The 2023-2028 Outlook for Schizophrenia Drugs in the United States

£520.00 23 Aug 2026
The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in the United States
99% match

The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in the United States

£520.00 11 Aug 2026
The 2023-2028 Outlook for Schizophrenia Treatments in Japan
99% match

The 2023-2028 Outlook for Schizophrenia Treatments in Japan

£495.00 13 Aug 2026
The 2023-2028 Outlook for Schizophrenia Therapeutics in Japan
99% match

The 2023-2028 Outlook for Schizophrenia Therapeutics in Japan

£495.00 26 Sep 2026
The 2023-2028 Outlook for Schizophrenia Drugs in Japan
98% match

The 2023-2028 Outlook for Schizophrenia Drugs in Japan

£495.00 19 Aug 2026
The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in Japan
98% match

The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in Japan

£495.00 19 Aug 2026
The 2023-2028 Outlook for First Generation Antipsychotic Drugs for Schizophrenia in Japan
98% match

The 2023-2028 Outlook for First Generation Antipsychotic Drugs for Schizophrenia in Japan

£495.00 19 Aug 2026
The 2023-2028 Outlook for First Generation Antipsychotic Drugs for Schizophrenia for US Zip Codes
97% match

The 2023-2028 Outlook for First Generation Antipsychotic Drugs for Schizophrenia for US Zip Codes

£490.00 21 Oct 2026
Schizophrenia Treatment - The New Facets
97% match

Schizophrenia Treatment - The New Facets

IntechOpen

£101.15 11 Sep 2026
Schizophrenia in the 21st Century
97% match

Schizophrenia in the 21st Century

IntechOpen

£114.00 27 Sep 2026
New Approaches to the Management and Diagnosis of Schizophrenia
97% match

New Approaches to the Management and Diagnosis of Schizophrenia

IntechOpen

£119.00 24 Sep 2026
Schizophrenia: Effects on Daily Life (DVD) (Concept Media: Educational Videos)
97% match

Schizophrenia: Effects on Daily Life (DVD) (Concept Media: Educational Videos)

Cengage Learning

£302.40 20 Oct 2026
Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework: 63 (Current Topics in Behavioral Neurosciences, 63)
97% match

Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework: 63 (Current Topics in Behavioral Neurosciences, 63)

Springer

£83.21 12 Oct 2026
Schizophrenia: A Contemporary Introduction (Routledge Introductions to Contemporary Psychoanalysis)
97% match

Schizophrenia: A Contemporary Introduction (Routledge Introductions to Contemporary Psychoanalysis)

Routledge

£138.43 19 Sep 2026
Schizophrenia: An Integrated View Albert Benzon Symposium 38: v. 38 (Alfred Benzon Symposium Series)
97% match

Schizophrenia: An Integrated View Albert Benzon Symposium 38: v. 38 (Alfred Benzon Symposium Series)

Wiley-Blackwell

Price unavailable
Schizophrenie:: Interaktionsprozesse Und Emotionales Klima in Der Familie: 308 (Europaeische Hochschulschriften / European University Studie)
97% match

Schizophrenie:: Interaktionsprozesse Und Emotionales Klima in Der Familie: 308 (Europaeische Hochschulschriften / European University Studie)

Peter Lang Gmbh, Internationaler Verlag Der Wissenschaften

£72.35 20 Oct 2026
Self Fragmentation and Integration in Schizophrenia - Volume 1
97% match

Self Fragmentation and Integration in Schizophrenia - Volume 1

Nova Science Publishers Inc

£101.67 17 Oct 2026
A Phenomenological Interpretation of Schizophrenia: Subjectivation, Framework and Perspective
97% match

A Phenomenological Interpretation of Schizophrenia: Subjectivation, Framework and Perspective

Springer

£80.65 22 Sep 2026
Negative and Cognitive Symptoms in Schizophrenia (Comprehensive Approach to Psychiatry, 3)
97% match

Negative and Cognitive Symptoms in Schizophrenia (Comprehensive Approach to Psychiatry, 3)

Springer

£95.74 25 Sep 2026
Schizophrenie: Dopaminrezeptoren und Neuroleptika
97% match

Schizophrenie: Dopaminrezeptoren und Neuroleptika

Springer

£64.22 17 Sep 2026
Controversies in Schizophrenia: Issues, Causes, Treatment
97% match

Controversies in Schizophrenia: Issues, Causes, Treatment

Routledge

£151.26 09 Oct 2026
Social Skills Training for Schizophrenia, Third Edition: A Step-by-Step Guide
97% match

Social Skills Training for Schizophrenia, Third Edition: A Step-by-Step Guide

The Guilford Press

£89.22 30 Sep 2026
Ethical and Clinical Complexities in the Treatment of Schizophrenia: Liberty or Life
96% match

Ethical and Clinical Complexities in the Treatment of Schizophrenia: Liberty or Life

Cambridge University Press

£48.02 07 Oct 2026
Schizophrenia
96% match

Schizophrenia

£87.76 18 Sep 2026